Capital Rx is a full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) that is transforming the way prescription drugs are priced and patients are served in the U.S. Through its cloud-based enterprise health platform JUDI, Capital Rx connects every aspect of the pharmacy ecosystem to increase efficiency, transparency and clinical care. Capital Rx services over 2.4 million members across Medicare, Medicaid and commercial plans.
Capital Rx was founded in 2017 by CEO AJ Loiacono, COO Joseph Alexander, and CTO Ryan Kelly. Loiacono. Building on a vision to disrupt the opaque PBM industry, Capital Rx has raised over $250 million to date from top investors including B Capital Group and Transformation Capital. The company has achieved significant growth, with $429 million in revenue in 2021 and an estimated $814 million in 2022.
The fast-growing 250+ person team is dedicated to using advanced technology to improve drug affordability and access. While the company faces intense competition from entrenched PBM giants, Capital Rx's modern platform and transparent pricing model position it to continue its rapid ascent in the $335 billion prescription drug market. Capital Rx represents an opportunity to drive meaningful industry transformation at a company entering an exciting new stage of growth.
2017
Founded
250-500
Employees
Series E
Stage
$1B-$3B
Latest Valuation
$200-400M
Total Funding
Mar 21 2024
Last Fundraise
Why is the rating
Top Previous Employers

CVS

Elixir

Optum

UnitedHealth Group

Walgreens
Investors

General Catalyst
Airbnb, Snap, Gusto